Genetic alterations in hormone-refractory recurrent prostate carcinomas.
暂无分享,去创建一个
T. Visakorpi | P. Koivisto | L. Kakkola | N. Nupponen | T Visakorpi | N N Nupponen | P Koivisto | L Kakkola
[1] P. Walsh,et al. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. , 1993, Cancer research.
[2] W. Isaacs,et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.
[3] Stefan Joos,et al. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization , 1995, Genes, chromosomes & cancer.
[4] Arthur R. Brothman,et al. Mutation of the MXI1 gene in prostate cancer , 1995, Nature Genetics.
[5] M. Bittner,et al. DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] L. Liotta,et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. , 1995, Cancer research.
[7] John Calvin Reed,et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. , 1996, The American journal of pathology.
[8] D. Grignon,et al. Allelic loss in locally metastatic, multisampled prostate cancer. , 1994, Cancer research.
[9] S. Devries,et al. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. , 1994, The American journal of pathology.
[10] T. Visakorpi,et al. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. , 1994, The American journal of pathology.
[11] R. Matusik,et al. Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. , 1986, Cancer research.
[12] K. Offit,et al. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma , 1996 .
[13] Yiwei Li,et al. Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas , 1992, The Prostate.
[14] M. Campbell,et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. , 1992, Cancer research.
[15] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[16] Camillo Ricordi,et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes , 1997, Nature Genetics.
[17] G. Buchanan,et al. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] D. Schaid,et al. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. , 1996, Cancer research.
[19] T. Visakorpi,et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. , 1995, Cancer research.
[20] D. Pinkel,et al. Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .
[21] P. Carroll,et al. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). , 1995, The Journal of urology.
[22] J Piper,et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.
[23] A. Yang,et al. Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.
[24] J D Siegal,et al. Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers , 1988, The Prostate.
[25] G. Bubley,et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.
[26] A. Nagafuchi,et al. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. , 1997, Cancer research.
[27] K. Pritchard-Jones,et al. Novel formation and amplification of the PAX7‐FKHR fusion gene in a case of alveolar rhabdomyosarcoma , 1996 .
[28] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[29] R. Bookstein,et al. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer , 1994, Genes, chromosomes & cancer.
[30] W. Isaacs,et al. Allelic loss of chromosomes 16q and 10q in human prostate cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Chopin,et al. Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. , 1993, The American journal of pathology.
[32] T. Visakorpi,et al. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. , 1994, Cytometry.
[33] P. Scardino,et al. DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report. , 1991, Cancer research.
[34] V. P. Collins,et al. Allelotyping of human prostatic adenocarcinoma. , 1991, Genomics.
[35] E. Bergstralh,et al. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. , 1994, Cancer research.
[36] M. Henriksson,et al. Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.
[37] O. Brison,et al. Gene amplification and tumor progression. , 1993, Biochimica et biophysica acta.
[38] T. Visakorpi,et al. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model. , 1997, British Journal of Cancer.
[39] D. Bostwick,et al. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. , 1994, Cancer research.
[40] P. Carroll,et al. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. , 1996, Cancer research.
[41] T. Tammela,et al. Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy. , 1995, The American journal of pathology.
[42] K. Franssila,et al. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. , 1997, Blood.
[43] A. Schäffer,et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.
[44] D. Grignon,et al. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. , 1995, Cancer research.
[45] J Piper,et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Devries,et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization , 1995, Genes, chromosomes & cancer.
[47] Jorma Isola,et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.
[48] M. Stearns,et al. Prostate cancer: therapeutic, diagnostic, and basic studies. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[49] E. Schröck,et al. Advanced‐stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q , 1997, Genes, chromosomes & cancer.
[50] M. Stratton,et al. A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.
[51] W. Isaacs,et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. , 1994, Cancer research.
[52] D. Bostwick,et al. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.
[53] S. Hilsenbeck,et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. , 1995, The American journal of pathology.
[54] B. Scheithauer,et al. The Glial and Mesenchymal Elements of Gliosarcomas Share Similar Genetic Alterations , 1996, Journal of neuropathology and experimental neurology.
[55] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.